• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在羧酸辅助下扑热息痛II型结晶用于间歇和连续过程

Crystallization of Form II Paracetamol with the Assistance of Carboxylic Acids toward Batch and Continuous Processes.

作者信息

Yeh Kuan-Lin, Lee Hung-Lin, Lee Tu

机构信息

Department of Chemical and Materials Engineering, National Central University, 300 Zhongda Road, Zhongli District, Taoyuan City 320317, Taiwan.

出版信息

Pharmaceutics. 2022 May 20;14(5):1099. doi: 10.3390/pharmaceutics14051099.

DOI:10.3390/pharmaceutics14051099
PMID:35631685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9147162/
Abstract

Form II paracetamol has captured the interest of researchers due to its improved compressibility. However, its low stability has made it difficult to be produced on a large scale with good reproducibility. In the present study, the selective polymorphic formation of paracetamol was carried out by cooling crystallization with four types of additives: adipic acid, fumaric acid, oxalic acid, and succinic acid. It was found that: (1) the more additives that were added, the higher the probability of forming Form II paracetamol; (2) Form II paracetamol could be induced by seeding the paracetamol aqueous solution with Form II paracetamol and fumaric acid crystals, and not the other three carboxylic acids; (3) a new solution complex of paracetamol-oxalic acid, evidenced by the solubility diagram, was responsible for the selective nucleation of Form II paracetamol in the oxalic acid aqueous solution; and (4) the range of the degree of supersaturation for nucleating Form II paracetamol was extended with the assistance of oxalic acid or fumaric acid. In large-scale crystallization, Form II paracetamol was produced by the continuous crystallization of 44 mg of paracetamol/mL in 50 wt% of fumaric acid aqueous solution with a flow rate of 150 mL/min.

摘要

II型对乙酰氨基酚因其改善的可压缩性而引起了研究人员的兴趣。然而,其低稳定性使得难以大规模生产且具有良好的重现性。在本研究中,通过用四种添加剂(己二酸、富马酸、草酸和琥珀酸)进行冷却结晶来实现对乙酰氨基酚的选择性多晶型形成。结果发现:(1)添加的添加剂越多,形成II型对乙酰氨基酚的概率越高;(2)用II型对乙酰氨基酚和富马酸晶体而不是其他三种羧酸对乙酰氨基酚水溶液进行晶种接种,可以诱导形成II型对乙酰氨基酚;(3)由溶解度图证明的对乙酰氨基酚 - 草酸新溶液络合物,是草酸水溶液中II型对乙酰氨基酚选择性成核的原因;(4)在草酸或富马酸的辅助下,II型对乙酰氨基酚成核的过饱和度范围得以扩展。在大规模结晶中,通过在50 wt%的富马酸水溶液中以150 mL/min的流速连续结晶44 mg/mL的对乙酰氨基酚来生产II型对乙酰氨基酚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/dba05a3b6e95/pharmaceutics-14-01099-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/d4d96c3f20d8/pharmaceutics-14-01099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/68ad05ead5b6/pharmaceutics-14-01099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/8762910b6a66/pharmaceutics-14-01099-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/f81aa24f0304/pharmaceutics-14-01099-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/35bc8c1a8894/pharmaceutics-14-01099-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/ae1b56572064/pharmaceutics-14-01099-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/3a03c65e8403/pharmaceutics-14-01099-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/569497f12dcc/pharmaceutics-14-01099-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/0cad955c5b63/pharmaceutics-14-01099-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/6a4b974d6dd8/pharmaceutics-14-01099-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/fa0e63b469a7/pharmaceutics-14-01099-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/dba05a3b6e95/pharmaceutics-14-01099-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/d4d96c3f20d8/pharmaceutics-14-01099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/68ad05ead5b6/pharmaceutics-14-01099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/8762910b6a66/pharmaceutics-14-01099-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/f81aa24f0304/pharmaceutics-14-01099-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/35bc8c1a8894/pharmaceutics-14-01099-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/ae1b56572064/pharmaceutics-14-01099-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/3a03c65e8403/pharmaceutics-14-01099-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/569497f12dcc/pharmaceutics-14-01099-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/0cad955c5b63/pharmaceutics-14-01099-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/6a4b974d6dd8/pharmaceutics-14-01099-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/fa0e63b469a7/pharmaceutics-14-01099-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/9147162/dba05a3b6e95/pharmaceutics-14-01099-g012.jpg

相似文献

1
Crystallization of Form II Paracetamol with the Assistance of Carboxylic Acids toward Batch and Continuous Processes.在羧酸辅助下扑热息痛II型结晶用于间歇和连续过程
Pharmaceutics. 2022 May 20;14(5):1099. doi: 10.3390/pharmaceutics14051099.
2
Succinic, fumaric, adipic and oxalic acid cocrystals of promethazine hydrochloride.盐酸异丙嗪的琥珀酸、富马酸、己二酸和草酸共晶体。
Acta Crystallogr C Struct Chem. 2019 Feb 1;75(Pt 2):107-119. doi: 10.1107/S2053229618017904. Epub 2019 Jan 16.
3
An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression.采用反溶剂结晶技术,在各种添加剂存在的情况下,对扑热息痛晶体进行工程改造,以便直接进行压缩。
Int J Pharm. 2014 Apr 10;464(1-2):53-64. doi: 10.1016/j.ijpharm.2014.01.026. Epub 2014 Jan 27.
4
A study of the changes during heating of paracetamol.对乙酰氨基酚加热过程中的变化研究。
Drug Dev Ind Pharm. 1998 May;24(5):447-53. doi: 10.3109/03639049809085642.
5
Effects of initial concentration and seeding procedure on crystallisation of orthorhombic paracetamol from ethanolic solution.初始浓度和接种程序对乙醇溶液中正交晶型扑热息痛结晶的影响。
Int J Pharm. 2003 Jul 9;260(1):123-35. doi: 10.1016/s0378-5173(03)00252-7.
6
Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.与二羧酸形成的盐和共晶的西地那非:戊二酸盐的溶解度和药代动力学优势。
Mol Pharm. 2013 Dec 2;10(12):4687-97. doi: 10.1021/mp400516b. Epub 2013 Nov 8.
7
Crystallization of a polymorphic hydrate system.多晶型水合物体系的结晶。
J Pharm Sci. 2010 Feb;99(2):753-63. doi: 10.1002/jps.21865.
8
Evaluation of growth rate constants of oxalic acid dihydrate at constant supersaturation.恒定过饱和度下二水合草酸生长速率常数的评估。
J Pharm Sci. 1986 Jun;75(6):559-61. doi: 10.1002/jps.2600750607.
9
Predicting the crystallization propensity of carboxylic acid buffers in frozen systems--relevance to freeze-drying.预测冷冻体系中羧酸缓冲液的结晶倾向——与冷冻干燥的相关性。
J Pharm Sci. 2011 Apr;100(4):1288-93. doi: 10.1002/jps.22374. Epub 2010 Dec 9.
10
Formulation and solid state characterization of carboxylic acid-based co-crystals of tinidazole: An approach to enhance solubility.替硝唑羧酸基共晶体的配方及固态表征:一种提高溶解度的方法
Polim Med. 2018 Jul-Dec;48(2):99-104. doi: 10.17219/pim/105609.

引用本文的文献

1
Process Analytical Technology Obtained Metastable Zone Width, Nucleation Rate and Solubility of Paracetamol in Isopropanol-Theoretical Analysis.过程分析技术获得的对乙酰氨基酚在异丙醇中的亚稳区宽度、成核速率和溶解度——理论分析
Pharmaceuticals (Basel). 2025 Feb 24;18(3):314. doi: 10.3390/ph18030314.

本文引用的文献

1
Color polymorphism in organic crystals.有机晶体中的颜色多态性。
Commun Chem. 2020 Mar 17;3(1):34. doi: 10.1038/s42004-020-0279-0.
2
A Novel Hydrate Form of Sodium Dodecyl Sulfate and Its Crystallization Process.一种新型十二烷基硫酸钠水合物形式及其结晶过程。
ACS Omega. 2021 Jun 8;6(24):15770-15781. doi: 10.1021/acsomega.1c01147. eCollection 2021 Jun 22.
3
Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity.探索洗涤过程中反溶剂效应在活性药物成分纯度方面的作用。
Org Process Res Dev. 2021 Apr 16;25(4):969-981. doi: 10.1021/acs.oprd.1c00005. Epub 2021 Mar 12.
4
State-of-the-Art Chocolate Manufacture: A Review.巧克力制造的最新技术:综述
Compr Rev Food Sci Food Saf. 2017 Nov;16(6):1313-1344. doi: 10.1111/1541-4337.12301. Epub 2017 Sep 12.
5
Concerning Elusive Crystal Forms: The Case of Paracetamol.关于难以捉摸的晶体形态:对扑热息痛的案例分析。
J Am Chem Soc. 2020 Apr 8;142(14):6682-6689. doi: 10.1021/jacs.0c00321. Epub 2020 Mar 27.
6
The Chemistry behind Chocolate Production.巧克力制作的化学原理。
Molecules. 2019 Aug 30;24(17):3163. doi: 10.3390/molecules24173163.
7
Reassessment of paracetamol orthorhombic Form III and determination of a novel low-temperature monoclinic Form III-m from powder diffraction data.对扑热息痛正交晶型III的重新评估以及从粉末衍射数据确定一种新型低温单斜晶型III-m
Acta Crystallogr C Struct Chem. 2018 Mar 1;74(Pt 3):392-399. doi: 10.1107/S2053229618002619. Epub 2018 Feb 28.
8
Development of paracetamol-caffeine co-crystals to improve compressional, formulation and in vivo performance.开发对乙酰氨基酚-咖啡因共晶以改善压缩、制剂和体内性能。
Drug Dev Ind Pharm. 2018 Jul;44(7):1099-1108. doi: 10.1080/03639045.2018.1435687. Epub 2018 Feb 15.
9
Inkjet printing of paracetamol and indomethacin using electromagnetic technology: Rheological compatibility and polymorphic selectivity.喷墨打印使用电磁技术的扑热息痛和吲哚美辛:流变兼容性和多晶型选择性。
Eur J Pharm Sci. 2018 Mar 30;115:248-257. doi: 10.1016/j.ejps.2018.01.036. Epub 2018 Jan 31.
10
Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids.对包含对乙酰氨基酚和二羧酸的药物共晶的相对稳定性进行比较。
Drug Dev Ind Pharm. 2018 Apr;44(4):582-589. doi: 10.1080/03639045.2017.1405433. Epub 2017 Nov 29.